Stock Market News

AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn’s Disease

wcc wcc
Mar 09, 2026 - 09:50
0 2
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn’s Disease
Previous Article

Formula 1 and Salesforce, Inc. (CRM) Announce Deepened Partnership

Next Article

Barclays Cuts PT on Blackstone Inc. (BX) to $126 From $164 – Here’s Why

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Meta's flurry of AI initiatives this month hasn't he...

wcc
Jun 26, 2026
0
0
Market Update: BDX, DD

Market Update: BDX, DD

wcc
Jun 26, 2026
0
0
Earnings Preview: What To Expect From Cintas' Report

Earnings Preview: What To Expect From Cintas' Report

wcc
Jun 26, 2026
0
0
Qualcomm strikes Modular deal to boost agentic AI software stack

Qualcomm strikes Modular deal to boost agentic AI so...

wcc
Jun 26, 2026
0
0

Gavin Newsom calls for national billionaires tax: 'I...

wcc
Jun 26, 2026
0
0
Ecarx to acquire the Flyme entire software business

Ecarx to acquire the Flyme entire software business

wcc
Jun 26, 2026
0
0

Comments (0)

User